Condensed interim consolidated statements of operations and comprehensive loss (USD $)	3 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Net revenues	$ 63,732,361	$ 71,754,957
Cost of revenues	(67,971,371)	(57,723,757)
Gross profit / (loss)	(4,239,010)	14,031,200
Operating expenses:
Research and development expenses	(1,545,036)	(486,274)
Sales and marketing expenses	(2,188,015)	(1,957,670)
General and administrative expenses	(9,967,151)	(5,770,772)
Impairment charge on property, plant and equipment	0	(2,707,686)
Total operating expenses	(13,700,202)	(10,922,402)
Operating income/(loss)	(17,939,212)	3,108,798
Finance costs, net	(2,734,119)	(2,882,729)
Loss arising from loan guarantees	(7,360,706)	0
Government grant income	18,242	48,305
Other income/(expenses)	(117,948)	19,882
Income/(loss) before income taxes	(28,133,743)	294,256
Income tax expenses	(32,006)	(2,114,010)
Net loss	(28,165,749)	(1,819,754)
Net loss	(28,165,749)	(1,819,754)
Other comprehensive income
- Foreign currency translation adjustment	931,440	1,791,087
Comprehensive loss	$ (27,234,309)	$ (28,667)
Net loss per share:
- Basic	$ (2.23)	$ (0.14)
- Diluted	$ (2.23)	$ (0.14)
Weighted average number of shares of common stock:
- Basic	12,619,597	12,619,049
- Diluted	12,619,597	12,619,049